2Morrow named Top Vendor for Cessation by Shortlister

Previous
Previous

NIH SBIR - Center For Scientific Review Special Emphasis Panel in DC on July 6-7

Next
Next

Jo Masterson, CEO at 2Morrow, was invited to participate in the White House Cancer Moonshot